These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34684252)

  • 1. Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis.
    León-Buitimea A; Garza-Cervantes JA; Gallegos-Alvarado DY; Osorio-Concepción M; Morones-Ramírez JR
    Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of invasive fungal infection.
    Castón-Osorio JJ; Rivero A; Torre-Cisneros J
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal infections in the immunocompromised host.
    Hawkins C; Armstrong D
    Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus.
    Trief D; Gray ST; Jakobiec FA; Durand ML; Fay A; Freitag SK; Lee NG; Lefebvre DR; Holbrook E; Bleier B; Sadow P; Rashid A; Chhabra N; Yoon MK
    Br J Ophthalmol; 2016 Feb; 100(2):184-8. PubMed ID: 26112869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
    Rybak JM; Marx KR; Nishimoto AT; Rogers PD
    Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FUNGUS DISEASES OF THE LUNGS].
    BUSCHMANN O
    Fortschr Geb Rontgenstr Nuklearmed; 1963 Sep; 99():284-93. PubMed ID: 14098977
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifungal prophylaxis during neutropenia and immunodeficiency.
    Lortholary O; Dupont B
    Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive mould infections in the ICU setting: complexities and solutions.
    Bassetti M; Bouza E
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ENDOMYCOSES FROM THE VIEWPOINTS OF HUMAN AND VETERINARY MEDICINE].
    GEMEINHARDT H
    Dtsch Gesundheitsw; 1964 Feb; 19():350-8. PubMed ID: 14171957
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology and clinical manifestations of mucormycosis.
    Petrikkos G; Skiada A; Lortholary O; Roilides E; Walsh TJ; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S23-34. PubMed ID: 22247442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on antifungal treatment of invasive Candida and Aspergillus infections.
    Maschmeyer G; Ruhnke M
    Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of fungal infections in animals.
    Lehmann PF
    Vet Immunol Immunopathol; 1985 Oct; 10(1):33-69. PubMed ID: 3909619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RESPIRATORY MYCOSES].
    FAVEZ G; VULLIEMOZ P
    Rev Med Suisse Romande; 1963 Aug; 83():671-733. PubMed ID: 14083514
    [No Abstract]   [Full Text] [Related]  

  • 16. [State of the art in invasive diseases by filamentous fungi].
    Pemán J; Quindós G
    Rev Iberoam Micol; 2014; 31(4):213-8. PubMed ID: 25449676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens.
    Friedman DZP; Schwartz IS
    J Fungi (Basel); 2019 Jul; 5(3):. PubMed ID: 31330862
    [No Abstract]   [Full Text] [Related]  

  • 18. Focus on fungal infections.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.